August 11, 2025

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Unveiling a 39.75% Potential Upside in RNA-targeted Medicine

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leader in RNA-targeted therapies, has captured investor attention with its robust product portfolio and a compelling potential upside of 39.75%...

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating a Healthcare Giant with a Strong Return on Equity

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a titan in the healthcare sector, specializing in diagnostics and research. Founded in 1992 and headquartered in Cincinnati, Ohio,..

ADMA Biologics Inc (ADMA): Analyzing Its 75.91% Potential Upside for Investors

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, offers a compelling investment opportunity with a notable potential upside of 75.91%. As a..

Revolution Medicines (RVMD): An Investor’s Insight into a 105.71% Potential Upside in Precision Oncology

Revolution Medicines, Inc. (NASDAQ: RVMD) is making waves in the biotechnology sector, particularly in the field of precision oncology. With a market cap of $6.54 billion,..

Guardant Health (GH) Stock Analysis: A Promising Opportunity with 12.99% Upside Potential

Guardant Health, Inc. (NASDAQ: GH), a leading player in the precision oncology sector, is capturing investor attention with its innovative diagnostic solutions and an attractive upside..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a Potential 22% Upside for Investors

Koninklijke Philips N.V. (NYSE: PHG), a titan in the healthcare sector, specifically in medical devices, commands significant investor attention with its current market cap of $25.51..

DexCom, Inc. (DXCM) Investor Outlook: 29% Potential Upside with Strong Buy Ratings

DexCom, Inc. (NASDAQ: DXCM) is a prominent player in the healthcare sector, specifically within the medical devices industry, focusing on continuous glucose monitoring (CGM) systems. Headquartered..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 20.99% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) is capturing the attention of investors with its substantial potential upside of 20.99%, according to analyst ratings. This Utah-based company,..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Exploring a 64% Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) presents an intriguing opportunity for investors seeking exposure in the healthcare sector, specifically within the biotechnology industry. Headquartered in Dublin, Ireland,..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 32.34% Upside Potential

Integer Holdings Corporation (NYSE: ITGR) presents an intriguing opportunity for investors keen on the healthcare sector, specifically within the medical device industry. With a substantial market..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Unpacking a 26% Upside Potential

For investors with a keen eye on the healthcare sector, Prestige Consumer Healthcare Inc. (NYSE: PBH) presents an intriguing opportunity. Known for its robust portfolio of..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a -27% Potential Downside amid Revenue Growth

Oscar Health, Inc. (OSCR), a prominent player in the healthcare technology sector, presents a complex investment profile that demands careful scrutiny from individual investors. Headquartered in..

Halozyme Therapeutics, Inc. (HALO): Investor Outlook and Growth Potential with a Strong Revenue Surge

Halozyme Therapeutics, Inc. (NASDAQ: HALO) has carved a niche in the biotechnology sector with its innovative enzyme-based therapies, positioning itself as a formidable player in the..

Waystar Holding Corp. (WAY) Stock Analysis: 45.66% Upside Potential in Healthcare Tech

Waystar Holding Corp. (NASDAQ: WAY), a prominent player in the healthcare technology sector, is capturing significant attention from investors with its robust potential upside of 45.66%...

Nuvalent, Inc. (NUVL) Stock Analysis: A Biotech with a 56.89% Potential Upside

Nuvalent, Inc. (NASDAQ: NUVL), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising clinical-stage cancer therapies. Despite operating at..

Bio-Techne Corp (TECH) Stock Analysis: Evaluating a 29.48% Potential Upside for Biotech Investors

Bio-Techne Corp (TECH), a significant player in the biotechnology industry, presents a compelling investment opportunity for those eyeing the healthcare sector. With a market capitalization of..

Avantor, Inc. (AVTR) Stock Analysis: A Closer Look at Its 22.76% Potential Upside

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $7.84 billion,..

Roivant Sciences Ltd. (ROIV) Investor Outlook: Biotechnology Innovator with a 47.89% Potential Upside

Roivant Sciences Ltd. (ROIV), a pioneering entity in the biotechnology sector, is capturing the attention of investors with its innovative approach to drug discovery and development...

Danaher Corporation (DHR) Stock Analysis: A Healthcare Powerhouse with a 23% Upside

Investors looking to navigate the intricate world of healthcare stocks might find Danaher Corporation (NYSE: DHR) particularly enticing. With its robust presence in the diagnostics and..

Veeva Systems Inc. (VEEV) Stock Analysis: Uncovering Growth Potential with a 16.7% Revenue Surge

Veeva Systems Inc. (NYSE: VEEV), a leader in cloud-based software solutions for the life sciences industry, presents a compelling case for investors with its robust revenue..

Search

Funds

August 11, 2025

Search

Funds

August 11, 2025

FTSE 100

Funds